Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells
- PMID: 27659811
- DOI: 10.1016/j.bcp.2016.09.013
Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells
Abstract
Posttranslational modifications of histone tails can alter chromatin structure and regulate gene transcription. While recent studies implicate the lysine/arginine protein methyltransferases in the regulation of genes for endothelial metabolism, the role of AMI-1 and AMI-5 compounds in angiogenesis remains unknown. Here, we show that global inhibition of arginine and lysine histone methyltransferases (HMTs) by AMI-5 induced an angiostatic profile in human microvascular endothelial cells and human umbilical vein endothelial cells. Based on FACS analysis, we found that inhibition of HMTs significantly affects proliferation of endothelial cells, by suppressing cell cycle progression in the G0/G1 phase. Immunofluorescent studies of the endothelial cells replication pattern by 5-ethynyl-2'-deoxyuridine incorporation disclosed that AMI-5, and the arginine methyltransferase inhibitor AMI-1, induced heterochromatin formation and a number of nuclear abnormalities, such as formation of micronuclei (MNs) and nucleoplasmic bridges (NPBs), which are markers of chromosomal instability. In addition to the modification of the cell cycle machinery in response to AMIs treatment, also endothelial cells migration and capillary-like tube formation processes were significantly inhibited, implicating a stimulatory role of HMTs in angiogenesis.
Keywords: Angiogenesis process; Arginine/lysine histone methyltransferases; Endothelial cells.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Endothelial transcriptome in response to pharmacological methyltransferase inhibition.ChemMedChem. 2014 Aug;9(8):1755-62. doi: 10.1002/cmdc.201402091. Epub 2014 May 21. ChemMedChem. 2014. PMID: 24850797
-
Design, synthesis and biological evaluation of carboxy analogues of arginine methyltransferase inhibitor 1 (AMI-1).ChemMedChem. 2010 Mar 1;5(3):398-414. doi: 10.1002/cmdc.200900459. ChemMedChem. 2010. PMID: 20091730
-
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.Oncotarget. 2015 Sep 8;6(26):22799-811. doi: 10.18632/oncotarget.4332. Oncotarget. 2015. PMID: 26078354 Free PMC article.
-
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?Mol Oncol. 2016 Dec;10(10):1497-1515. doi: 10.1016/j.molonc.2016.09.003. Epub 2016 Sep 23. Mol Oncol. 2016. PMID: 27717710 Free PMC article. Review.
-
Histone lysine methyltransferases as anti-cancer targets for drug discovery.Acta Pharmacol Sin. 2016 Sep;37(10):1273-1280. doi: 10.1038/aps.2016.64. Epub 2016 Jul 11. Acta Pharmacol Sin. 2016. PMID: 27397541 Free PMC article. Review.
Cited by
-
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCAMUT and BRCAWT Ovarian Cancer Cells.Cells. 2022 Jun 10;11(12):1889. doi: 10.3390/cells11121889. Cells. 2022. PMID: 35741017 Free PMC article.
-
PRMT4-mediated arginine methylation promotes tyrosine phosphorylation of VEGFR-2 and regulates filopodia protrusions.iScience. 2022 Jul 11;25(8):104736. doi: 10.1016/j.isci.2022.104736. eCollection 2022 Aug 19. iScience. 2022. PMID: 35942094 Free PMC article.
-
Silencing Lysine-Specific Histone Demethylase 1 (LSD1) Causes Increased HP1-Positive Chromatin, Stimulation of DNA Repair Processes, and Dysregulation of Proliferation by Chk1 Phosphorylation in Human Endothelial Cells.Cells. 2019 Oct 7;8(10):1212. doi: 10.3390/cells8101212. Cells. 2019. PMID: 31591366 Free PMC article.
-
Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.Mol Cell Biochem. 2023 May;478(5):1031-1044. doi: 10.1007/s11010-022-04577-z. Epub 2022 Oct 10. Mol Cell Biochem. 2023. PMID: 36214894
-
Cell‑specific histone modifications in atherosclerosis (Review).Mol Med Rep. 2018 Aug;18(2):1215-1224. doi: 10.3892/mmr.2018.9142. Epub 2018 Jun 6. Mol Med Rep. 2018. PMID: 29901135 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources